Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (UNCY) to Contact the Firm Before th...

Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (UNCY) to Contact the Firm Before the Securities Class Action Deadline on November 2, 2026 New York, New York--(Newsfile Corp. - October 5, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) ("Unicycive" or the "Company") on behalf of investors that purchased or otherwise acquired Unicycive securities between December 29, 2025 and June 29, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Unicycive and have suffered losses, you may CLICK HERE to contact us.